DCB News and Events
Follow us on our new DCB LinkedIn page!
Congratulations to poster and podium presentation award winners at the 2023 NCI Junior Investigator Meeting!
A recent Cancer Currents Blog features DCB-supported research and includes a perspective from Phil Daschner, a Program Director in DCB: Could Bacteria Help Find Cancer?
A recent Cancer Currents Blog features DCB-supported research: New Class of Compounds Rewires Cancer Cells to Self-Destruct
A recent Cancer Currents Blog features DCB-supported research and includes a perspective from Konstantin Salnikow, a Program Director in DCB: Loss of Y Chromosome in Men Makes Bladder Cancer More Aggressive
September 28, 2023
Health and Aging Trajectories: Shared and Competing Risks and Resiliencies for Chronic Diseases Associated with Aging
This workshop will highlight state-of-the-art knowledge from various disciplines exploring potential shared and competing risks and resiliencies influencing aging processes and major diseases of aging, and essential molecular pathways and processes that may be harnessed for disease prevention, interception, and management.
September 30, 2023 (3:00 - 3:30 pm ET)
Ovarian Cancer Awareness Month Twitter Chat (#OCAMChat23) - Part 2
This Twitter Chat being hosted by @NCICancerBio will discuss advances and opportunities in ovarian cancer research. Invited panelists who are members of the ovarian cancer research community will help lead the Twitter conversation.
October 16, 2023 (12:00 - 1:30 pm ET)
NIH Human Virome Program Technical Webinar
NIH program staff will discuss and answer questions about funding opportunities for the NIH Common Fund's Human Virome Program (RFA-RM-23-016, RFA-RM-23-017, RFA-RM-23-018, & RFA-RM-23-019).
October 20, 2023
40 Years of Cancer Epigenetics Symposium
This meeting is commemorating the 40th anniversary of important discoveries that launched the field of cancer epigenetics. It will discuss the progress of the field of cancer epigenetics and explore important research discoveries, cutting edge approaches, and future directions for this field.
October 24, 2023
Application Deadline for the Human Tumor Atlas Network (HTAN) Data Jamboree
The HTAN Data Jamboree will explore new approaches to analyze and integrate single-cell and spatial omics data from HTAN.
October 31, 2023 (12:30 - 1:30 pm ET)
SITC-NCI Computational Immuno-Oncology Webinar: Computational Approaches to the Optimization of the Dose and Schedule
Dr. Robert Jeraj (University of Wisconsin-Madison) will share computational approaches to improve immunotherapies in a webinar moderated by Dr. Matthew Reilley (University of Virginia).
November 3, 8, & 17, 2023 (1:30 - 5:15 pm ET)
Nanomedicine: Which Cancers to Treat?
This workshop will discuss which cancers are most suitable for nanotherapeutic treatments, how to match selected cancer targets with a successful nanotherapy, and how to overcome some of the critical biological/clinical barriers that have hampered the medical translation of nanotherapeutics.
November 8, 2023
Registration Deadline: NCI Cancer Health Disparities Ideation Minilabs
In these in-depth virtual minilabs, participants will collaborate and refine research themes that have emerged from the Visioning stage. The focus will be on creating strong and impactful themes and opportunities that can serve as the foundation for pioneering research in the field of Cancer Health Disparities.
November 14, 2023 (1:30 - 2:30 pm ET)
SITC-NCI Computational Immuno-Oncology Webinar: Impact of Non-Hematopoietic Cells on Anti-Tumor Immunity
Dr. Elana Fertig (Johns Hopkins School of Medicine) will discuss the effects of non-hematopoietic cells in immuno-oncology during a webinar moderated by Dr. Kellie Smith (Johns Hopkins School of Medicine).
December 4 - 8, 2023
Human Tumor Atlas Network (HTAN) Data Jamboree
The HTAN Data Jamboree will focus on a variety of activities using the HTAN atlas datasets with an emphasis on promoting the accessibility and reuse of HTAN data.
December 14, 2023 (12:30 - 1:30 pm ET)
SITC-NCI Computational Immuno-Oncology Webinar: Vaccines, Identifying Druggable Targets
Dr. Wei Zheng (Moderna) will discuss approaches for identifying targets for immuno-oncology vaccines during a webinar moderated by Dr. C. 'Harris' Floudas (NCI).